Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
4.86
-0.12 (-2.41%)
At close: Oct 16, 2025, 3:59 PM
4.61
-5.11%
After-hours: Oct 16, 2025, 05:41 PM EDT
-2.41% (1D)
| Bid | 4.61 |
| Market Cap | 15.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -29.07M |
| EPS (ttm) | -24.28 |
| PE Ratio (ttm) | -0.2 |
| Forward PE | -0.55 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 4.95 |
| Volume | 59,449 |
| Avg. Volume (20D) | 124,939 |
| Open | 5.00 |
| Previous Close | 4.98 |
| Day's Range | 4.67 - 5.07 |
| 52-Week Range | 4.11 - 66.00 |
| Beta | 0.59 |
| Ex-Dividend Date | n/a |
About CLRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLRB
Website n/a
3 months ago
-31.65%
Cellectar Biosciences shares are trading lower aft...
Unlock content with
Pro Subscription
4 months ago
+16.58%
Cellectar Biosciences shares are trading higher after the company announced initial results from the CLOVER-2 Phase 1 clinical trial evaluating iopofosine I 131 in relapsed/refractory pediatric high-grade glioma patients.
